SlideShare a Scribd company logo
MODULE- 5
FERMENTA
TIONAND
BLOOD PRODUCTS
BALASUNDARESAN M
B Pharmacy 6th sem
Subject: Pharmaceutical Biotechnology
SubjectCode: BP605T
Objectives of Course
•Appreciate the use of microorganisms
technology.
• Genetic engineering applications in relation
in fermentation
to production of
pharmaceuticals.
Learning Outcomes
• Students will learn about various fermentation methods
including their sterlization methods, aeration and stirring methods.
•They will also learn about various types of fermentor design and
parameters used to control fermentation process.
Definition:
Fermentation is the chemical transformation of organic
substances into simpler compounds by the action of
enzymes, complex organic catalysts, which are produced by
microorganisms such as molds, yeasts, or bacteria.
Enzymes act by hydrolysis, a process of breaking down or
predigesting complex organic molecules to form smaller
(and in the case of foods, more easily digestible)
compounds and nutrients.
HISTORY OF FERMENTATION
Fermentation is a natural process. People applied
fermentation to make products such as wine, mead (Made of
Fermented honey and water), cheese and beer long before the
biochemical process was understood. In the 1850s and
1860s Louis Pasteur became the first zymurgist (One who
expert in the field of fermentation) or scientist to study
fermentation when he demonstrated fermentation was
caused by living cells.
The first solid evidence of the living nature of yeast
appeared between 1837 and 1838 when three publications
appeared by C. Cagniard de la Tour, T. Swann, and F.
Kuetzing, each of whom independently concluded as a
result of microscopic investigations that yeast was a living
organism that reproduced by budding. The word "yeast," it
should be noted, traces its origins back to the Sanskrit word
meaning "boiling." It was perhaps because wine, beer, and
bread were each basic foods in Europe, that most of the early
studies on fermentation were done on yeasts, with which
they were made. Soon bacteria were also discovered; the
term was first used in English in the late 1840s, but it did not
come into general use until the 1870s, and then largely in
connection with the new germ theory of disease.
The view that fermentation was a process initiated by living
organisms soon aroused fierce criticism from the finest
chemists of the day, especially Justus von Liebig, J.J.
Berzelius, and Friedrich Woehler. This view seemed to give
new life to the waning mystical philosophy of vitalism, which
they had worked so hard to defeat. Proponents of vitalism held
that the functions of living organisms were due to a vital
principal (life force, chi, ki, prana , etc.) distinct from physico-
chemical forces, that the processes of life were not explicable
by the laws of physics and chemistry alone, and that life was in
some part self determining. As we shall soon see, the vitalists
played a key role in debate on the nature of
fermentation. A long battle ensued, and while it was
gradually recognized that yeast was a living organism, its
exact function in fermentations remained a matter of
controversy. The chemists still maintained that fermentation
was due to catalytic action or molecular vibrations.
The debate was finally brought to an end by the great French
chemist Louis Pasteur (1822-1895) who, during the 1850s
and 1860s, in a series of classic investigations, proved
conclusively that fermentation was initiated by living
organisms. In 1857 Pasteur showed that lactic acid
fermentation is caused by living organisms. In 1860 he
demonstrated that bacteria cause souring in milk, a process
formerly thought to be merely a chemical change, and his
work in identifying the role of microorganisms in food
spoilage led to the process of pasteurization. In 1877,
working to improve the French brewing industry, Pasteur
published his famous paper on fermentation, Etudes sur la
Biere , which was translated into English in 1879 as Studies
on Fermentation . He defined fermentation (incorrectly) as
"Life without air," but correctly showed specific types of
microorganisms cause specific types of fermentations and
specific end products. In 1877 the era of modern medical
bacteriology began when Koch (a German physician; 1843-
1910) and Pasteur showed that the anthrax bacillus caused
the infectious disease anthrax. This epic discovery led in
1880 to Pasteur's general germ theory of infectious disease,
which postulated for the first time that each such disease
was caused by a specific microorganism. Koch also made
the very significant discovery of a method for isolating
microorganisms in pure culture.
TYPES BASED ON RESPIRATION (AEROBIC AND
AN-AEROBIC)
Aerobic Fermentation: Aerobic fermentation means that
oxygen is present. Wine, beer and acetic acid vinegar (such
as apple cider vinegar), need oxygen in the “primary” or
first stage of fermentation.
When creating acetic vinegar, for example, exposing the
surface of the vinegar to as much oxygen as possible,
creates a healthy, flavorful vinegar with the correct pH.
Anaerobic Fermentation: Anaerobic fermentation is a
method cells use to extract energy from carbohydrates
when oxygen or other electron acceptors are not available
in the surrounding environment. This differentiates it from
anaerobic respiration, which doesn’t use oxygen but does
use electron-accepting molecules that come from outside
of the cell. The process can follow glycolysis as the next
step in the breakdown of glucose and other sugars to
produce molecules of adenosine triphosphate (ATP) that
create an energy source for the cell.
Through this method, a cell is able to regenerate
nicotinamide adenine dinucleotide (NAD+) from the
reduced form of nicotinamide adenine dinucleotide
(NADH), a molecule necessary to continue glycolysis.
Anaerobic fermentation relies on enzymes to add a
phosphate group to an individual adenosine diphosphate
(ADP) molecule to produce A
TP
, which means it is a form
of substrate-level phosphorylation. This contrasts with
oxidative phosphorylation, which uses energy from an
established proton gradient to produceA
TP
.
There are two major types of anaerobic fermentation:
ethanol fermentation and lactic acid fermentation. Both
restore NAD+ to allow a cell to continue generating ATP
through glycolysis.
Ethanol fermentation: Ethanol fermentation converts two
pyruvate molecules, the products of glycolysis, to two
molecules of ethanol and two molecules of carbon dioxide.
The reaction is a two-step process in which pyruvate is
converted to acetaldehyde and carbon dioxide first, by the
enzyme pyruvate decarboxylase.
Yeast and certain bacteria perform ethanol
where pyruvate (from glucose
fermentation
metabolism) is broken into ethanol and
carbon dioxide. The net chemical
for the production of ethanol from
equation
glucose
is:
C6H12O6 (glucose) → 2 C2H5OH (ethanol) + 2 CO2 (carbon dioxide)
Ethanol fermentation is used the production of beer, wine
and bread. It's worth noting that fermentation in the presence
of high levels of pectin result in the production of small
amounts of methanol, which is toxic when consumed.
Anaerobic fermentation -1
Lactic acid fermentation: Lactic acid fermentation is a
biological process by which glucose and other six-carbon
sugars (also, disaccharides of six-carbon sugars, e.g.
sucrose or lactose) are converted into cellular energy and
the metabolite lactate.
The pyruvate molecules from glucose metabolism
(glycolysis) may be fermented into lactic acid. Lactic acid
fermentation is used to convert lactose into lactic acid in
yogurt production. It also occurs in animal muscles when
the tissue requires energy at a faster rate than oxygen can be
supplied. The next equation for lactic acid production from
glucose is:
C6H12O6 (glucose) → 2 CH3CHOHCOOH (lacticacid)
The production of lactic acid from lactose and water may be
summarized as:
C12H22O11 (lactose) + H2O (water) → 4 CH3CHOHCOOH
(lactic acid)
Yogurt is made by fermenting milk. It's high in protein,
calcium, and probiotics ("good" bacteria). Here's how to
make yogurt and a look at the chemistry of yogurt.
TYPES OFFERMENTATION
Homo Lactic fermentation: The fermentation in which only
the lactic acid is produced. There is no any side product
formed after the reaction.
Hetero-Lactic Fermentation: The Fermentation in which the
lactic acid is produced along with some by products like
gases.
MECHANISM OF FERMENTATION
Fermentation takes place when the electron transport chain is
unusable (often due to lack of a final electron receptor, such
as oxygen), and becomes the cell’s primary means of ATP
(energy) production.[1] It turns NADH and pyruvate
produced in glycolysis into NAD+ and an organic molecule
(which varies depending on the type of fermentation; see
examples below). In the presence of O2, NADH and pyruvate
are used to generateA
TPin respiration. This iscalled
oxidative phosphorylation, and it generates much more ATP than
glycolysis alone. For that reason, cells generally benefit from
avoiding fermentation when oxygen is available, the exception
being obligate anaerobes which cannot tolerate oxygen.
The first step, glycolysis, is common to all fermentation
pathways this is the cause of fermentation:
C6H12O6 + 2 NAD+ + 2 ADP + 2 Pi → 2 CH3COCOO− + 2
NADH + 2A
TP+ 2 H2O + 2H+
Pyruvate is CH3COCOO−. Pi is inorganic phosphate. Two ADP
molecules and two Pi are converted to two ATP and two water
molecules via substrate-level phosphorylation. Two molecules of
NAD+ are also reduced to NADH.
In oxidative phosphorylation the energy for A
TP formation
is derived from an electrochemical proton gradient
generated across the inner mitochondrial membrane (or, in
the case of bacteria, the plasma membrane) via the
electron transport chain. Glycolysis has substrate-level
phosphorylation (ATP generated directly at the point of
reaction).
Humans have used fermentation to produce food and
beverages since the Neolithic age. For example,
fermentation is used for preservation in a process that
produces lactic acid as found in such sour foods as
pickled cucumbers, kimchi and yogurt (see fermentation
in food processing), as well as for producing alcoholic
beverages such as wine (see fermentation in
winemaking) and beer. Fermentation can even occur
within the stomachs of animals, such as humans.
PRODUCTS OF FERMENTATION
Wine
Beer
Lactic acid
Vinegar
Y
ogurts
 cheese
 Sauerkraut
 Kimchi
 Pepperoni
ETC………..
FERMENTER DESIGN
PRODUCTIONOF PENCILLIN
PRODUCTION OF GLUMATIC ACID
PRODUCTION OF CITRIC ACID
PRODUCTION GRISEOFULVIN
FERMENTATION AS A FOOD PRESERVATION
TECHNIQUE
Fermented foods are foods that have been prepared in a way so
that the bacteria naturally found within them starts to ferment.
Fermentation, also known as lacto-fermentation, is a chemical
process in which bacteria and other micro-organisms break
down starches and sugars within the foods, possibly making
them easier to digest, and resulting in a product that is filled
with helpful organisms and enzymes.
This process of fermentation is a natural preservative, which
means that fermented foods can last a long time.
ADVANTAGES AND DIS ADVANTAGES OF
FERMENTATION
Advantages of fermentation are that lactic acid can be
produced and it can produce energy forATPs.
Disadvantages of fermentation are that production can be
slow, the product is impure and needs to have further treatment
and the production carries a high cost and more energy.
IMPORTANCE OF FERMENTATION
Fermentation is important to cells that
don't have oxygen or cells that don't use
oxygen because:
1.It allows the cells to get 2 ATPgain from onemolecule
of glucose, even without oxygen.
2.Fermentation takes away the end products of glycolysis
so glycolysis can continue ... freeing up the electron
carriers, and so on.
3.Fermentation is important to the baking industry because
it is the process that yeast uses to produce the bubbles of
carbon dioxide that make the dough rise.
4.Fermentation is important in wineries and breweries
because yeast uses fermentation to produce alcohol.
5.Fermentation is important in muscles because it allows the
muscles to keep getting a little energy from glucose even
when the oxygen supply can't keep up with the demand.
Blood Products /
Substitutes
Introduction
Blood: It consistsof
1. Cells i.e. RBC, WBC, Platelets
2. Plasma i.e. Proteins, Coagulation factors
Blood Substitutes: It consistsof
1. Volume Expanders
2. Synthetic oxygen carriers
Blood Products: : Any therapeutic substance prepared from the blood. It consists of
Blood Components
Constituent separated from whole
blood
Plasma Derivatives
1. Red cell concentrate
2. Leuko-reduced RBC
3. Plasma
4. Plasma derivatives
5. Granulocyte concentrate
6. Platelet concentrate
1. Fresh frozen plasma
2. Cryoprecipitate
3. Albumin
4. Coagulation factors concentrate
5. Immunoglobulins
Collection
 350ml{301ml blood+49ml anticoagulant} is taken from previously
screened person .
 Tested for- syphilis, HBsAg, HCV, HIV 1&2
 Platelet concentrates for bacterial contamination
 Group determination (ABO & Rh) & presence of any RBC
antibody
 Processed into sub-components
Criteria for donor
▶ Normal body temperature, Blood pressure
▶ Weight above 50-55 kgs
▶ Normal Hb levels..
▶ Free from RTI, skin dz or blood dz
▶ No h/o drug addiction
▶ No h/o viral hepatitis
▶ No HIV infection or risk for it
▶ No h/o blood transfusion (<=6mo)
Whole Blood
▶ It is donor blood mixed with an anticoagulant
▶ Collected by venesection
▶ Collected in 63 ml of anticoagulant to form 450 ml.
“ “ “ 350 ml
OR, in 49 ml “ “ “
▶ Stored at 1-6º C
▶ Shelf Life up to 5 weeks
▶ 1 unit{350ml} will increase the Hb level of an
Adult (60-70Kg)
Pediatric pts
by 0.8 gm/dl
by 1gm/dl
• Indication :
• Exchange transfusions.
• Hemorrhage (>= 20%blood loss):
-To ↑O₂ carrying capacity
-volume replacement
-stabilize coagulation factors
Advantages :
• simple and inexpensive
• no special equipment required for
processing
Disadvantages :
•Risk of circulatory overload
•Maintaining at ~4oC leads to:
-platelet dysfunction
-degradation of coagulation
factors
-decreased 2,3 DPG levels
• Febrile reactions
• Narrow Shelf life- 5wks
Preservation techniques
▶ Chemical incorporation
▶ Rejuvenation solutions
▶ Additive solutions
▶ Red cell freezing
▶ Addition of buffers
Anticoagulants
Citrate -chief component of almost all anticoagulants used
chelates Ca2+ ... stops coagulation
Dextrose- energy source.
Phosphate- buffer
1. CG (sod.citrate+glucose)- 1st soln ever used
2. ACD (acid+citrate+dextrose)
3. CPD (citrate+phosphate+dextrose)- Higher pH & 2,3 DPG level is maintained.
SHELF-LIFE is 21 days.
4.CPDA
(+adenine)-
ATP production
ADP levels- glycolysis-
increases RBC viability to 35 days
5.SAG-M (saline+adenine+glucose+mannitol)-
maintains cell nutrition
increases viability to 42 days,
M-prevents spontaneous hemolysis
Red cel concentrate
Blood to separate under gravity (sedimentation method)
Or,Centrifugation done in special refrigerated centrifuge
Most of the plasma is removed and replaced with a solution of
glucose and adenine in saline to maintain viability of red cells.
 Maintained at temp : 2ºC to 6ºC
 High O₂ carrying capacity
 Optimal target for infusion- 7g/dl
 Indications:
- replacement of red cells in anemic patients
- acute massive blood loss
Advantages :
 Easy to prepare
 To avoid volume overload in c/o CCF
 Less chances of infection or alloimmunization
 Less immunosuppressant
 Dec. allergic reaction if plasma is also removed
Disadvantages :
 High Red cells to plasma ratio ↑viscosity
.·. ↑ time required for passing
through cannula & vessels
thus Hct should not exceed 80%
Platelet concentrates
 Platelets separated from plasma obtained after 4-6
donations are pooled
or,
from a single donor by plateletapheresis
 Composed of mainly platelets, some nonfunctional
WBCs, few RBCs & plasma[maintains pH].
volume= 50 ml contains 5.5x10^9/lt plts
Stored at 20-24oC
Shelf life- 5 days.. Once opened, transfuse within 6 hrs
1 unit of PC increases platelet count by: 5000-10000(adults)
20,000 (children)
75,000-1,00,000(infants)
If single donor- 1 unit of PC should contain >5.5 х 10 9platelets
If pooled then, > 250х 109 platelets
• Indications:
- Thrombocytopenia
- Platelet dysfunction
- Complication of anti-platelet
therapy(Clopidogrel)
- DIC
Fresh Frozen Plasma
 Stored at -40 to -50oC
 Composed of plasma, all coagulation factors, albumin & Ig
 1 unit= 200-250ml
 Plasma removed from a unit of whole blood & frozen (by
immersing in a solid carbondioxide and ethyl alcohol
 mixture) at/ below -25ºC within 4 hrs. ofcollection.
 Each unit of FFP increases the level of each clotting
factor by 2-3 %
 Shelf life: Frozen—1 year(<-30 degree centigrade)
Indications:
-active bleeding in pts with multiple factor
deficiencies
-surgery in patient with liver failure(treatment of choice)
-after massive transfusion
-DIC
-rapid reversal of warfarin(Prothrombim complex
concentrates,with factors II,IX,X can also be given)
-TTP
Advantage:
it is a acellular component so no chance of transmission of
intracellular infection
Cryoprecipitate
▶ When FFP is allowed to Thaw at 4oC, glutinous precipitate remains and,
if the suprenatant plasma is removed, cryoprecipitate
▶ contains factors VIII (very rich) , fibrinogen as well as factor XIII &
vwf.
at -40oC
▶Shelf life:2 years , if frozen
Used
1. If fibrinogen <1g/dl due to dilution
2. DIC
3. Von Willebrand disease and hemophilia VIII deficiency
Coagulation Factors
Factor VIII concentrate
 Prepared from large pools of donor plasma by fractionation process.
 Commercially prepared, lyophilized powder
 Hemophilia A & von Willebrand’s disease.
 Storage : 2 to 6°C
Factor IX
 Commercially prepared, lyophilized powder
 Hemophilia B
 Contains Factor II (prothrombin), VII,IX,X.
 Purified Factor IX contains only IX.
 Refrigerated at 35-45 °F
Immunoglobulin
▶ It is a concentrated solution of IgG
antibody component of plasma
▶ Prepared from large pools of donors
▶ Uses
1. To reduce infective complications in
patients with Ab deficiencies
2. Immunological d/o- Immune
thrombocytopenia, GBS
3. Anti-zoster Ig in varicella zoster
prophylaxis
4. Anti-Rhesus D Ig in pregnancy to
prevent hemolytic dsz in newborn
▶ Can Cause
▶ Acute renal failure ( in elderly)
▶ Acute reactions
Fibrinogen
▶ Prepared by organic liquid fractionation of plasma
▶ Stored in dried form
▶ Can be reconstituted with distilled water
▶ Used in cases of severe fibrinogendepletion
eg DIC, congenital afibrinogenaemia
▶ Carry high risk of hepatitis
Blood Substitutes
1. volume expanders
2. synthetic oxygen carriers
1.Volume expanders: inert compounds
• crystalloid-based • colloid-based
Ringer's lactate
Normal saline
D5W (dextrose 5% in water)
Dextrose with normal saline
Hypertonic saline
• Dextrans
• Albumin
• Gelofusin
• Hydroxyethyl starch
Crystalloids
a) Is isotonic, but with the
metabolism of glucose
 inside the body, becomes
hypotonic.
b) Blood cannot be given through
the same drip set otherwise
rouleaux formation will cause
clumping of RBCs
4) Dextrose Normal Saline (DNS)
a) Is hypertonic
b) But 1/5 NS +4.3% dextose and ¼ NS +5%
dextrose are isotonic and are best used as
maintenance fluids.
1) ) Ringer’s Lactate Solution(Hartman
Solution)
a) Consists of Na, Cl, K, Ca, Lactate. pH=6.5,
Osmolarity=273mmol/lt (slightly hypotonic)
b) Blood should not be given through the same drip set as
it contains Ca.
c) Crystalloid of choice for blood loss replacement.
2) ) Normal Saline {0.9% NaCl (isotonic)}
a) Preferred over RL for treating
• Hypochloremic metabolic alkalosis
• Brain injury (Ca2+ and lactate can increase the
neuronal injury)
• Hyponatremia
▶ 3)5% Dextose
Colloids
▶
▶ 1) Dextrans (Lomodex)
▶ Polysaccharides, can be stored for 10 years, half life=2-8 hours
▶ Advantages
a) Non toxic, neutral and chemically inert
b) Low molecular wt dextran improves microcirculation
▶ Drawbacks
a) Interfere with blood grouping and cross matching (by causing RBC aggregation, so a
blood sample should be taken before-hand)
b) Interferes with platelet function and is a/w abnormal bleeding (so total volume given
should not exceed 1000ml)
c) Can cause severe anaphylaxis
d) Large molecular weight dextrans can block renal tubules
e) ARDS (rarely) because of direct toxic effect on pulmonary capillaries
▶ 2)Albumin(available as 5% and 20% solution)
▶ Very expensive, intravascular half-life= 10-15days
▶ Used in protein loss like, peritonitis, liver failure, burns, protein losing enterepathies.
▶ 20% is hypertonic and expands plasma volume by more than the amount infused.
▶ Stored for several months in liquid form at 4degree
▶ 3)Gelatins (Haemaccel)(available as 3.5% solution)
▶ Consists of Gelatin, Na, Cl, K, Ca
▶ Expand plasma effectively for 2 hours
▶ At clinically used doses, these do not interfere with blood grouping, plt fxn and clotting
but at high doses can interfere clotting.
▶ As it contains high Calcium, citrated blood should not be mixed.
Synthetic oxygen carriers:
mimic blood's O₂ transport ability
Types
1. Abiotic - perfluorocarbons, perfluoroctyl bromide
2. Biomimetic - HBOC( Hb based oxygen carriers)
- recombinant erythropoietin, hemoglobin under clinical trials
some available products:
Hemopure
Oxygent
PolyHeme
Perfluorocarbons
▶ High O₂ carryingcapacity
▶ Emulsified and transfused
▶ Short survival in the circulation
▶ Adverse effects : Flu like symptoms.
Immunologic effects.
HBOC
▶ Hb synthesised by controlled lysis of Red
Cells
▶ Short half life as compared to RBCs
▶ Side effects :
GI distress, neurotoxicity,
vasoconstriction,
interfere with macrophage system.
FERMENTATION.pptx

More Related Content

Similar to FERMENTATION.pptx

Fermentation and Microorganisms lesson 1.pptx
Fermentation and Microorganisms lesson 1.pptxFermentation and Microorganisms lesson 1.pptx
Fermentation and Microorganisms lesson 1.pptx
zahrarafi3
 
Food fermentation
Food fermentationFood fermentation
Food fermentation
Shifa Killedar
 
Fermentation Presentation.pdf
Fermentation Presentation.pdfFermentation Presentation.pdf
Fermentation Presentation.pdf
LaxmanBulbule1
 
Fermentation.pptx
Fermentation.pptxFermentation.pptx
Fermentation.pptx
ArifUddin50
 
Fermentation presentation
Fermentation presentationFermentation presentation
Fermentation presentationkhehkesha
 
Explain the difference between fermentation and respiration in biolo.pdf
Explain the difference between fermentation and respiration in biolo.pdfExplain the difference between fermentation and respiration in biolo.pdf
Explain the difference between fermentation and respiration in biolo.pdf
indiaartz
 
Fermentation of carbohydrates
Fermentation of carbohydratesFermentation of carbohydrates
Fermentation of carbohydratesShalini Saini
 
Fermentation and it's types
Fermentation and it's typesFermentation and it's types
Fermentation and it's types
Muhammad Hassan Malik
 
Life sciences ebook
Life sciences  ebookLife sciences  ebook
Life sciences ebook
Lebogang Sefoko
 
3.7 cell respiration
3.7 cell respiration3.7 cell respiration
3.7 cell respirationcartlidge
 
3 130909221817-
3 130909221817-3 130909221817-
3 130909221817-
Banele Ngomane
 
Respiration in Plants Class 11 Free Study Material pdf download
Respiration in Plants Class 11 Free Study Material pdf downloadRespiration in Plants Class 11 Free Study Material pdf download
Respiration in Plants Class 11 Free Study Material pdf download
Vivekanand Anglo Vedic Academy
 
Bacterial Metabolism.docx
Bacterial Metabolism.docxBacterial Metabolism.docx
Bacterial Metabolism.docx
SumanRiaz5
 
PLANT RESPIRATION.pptx
PLANT RESPIRATION.pptxPLANT RESPIRATION.pptx
Bacterial Metabolism.pdf
Bacterial Metabolism.pdfBacterial Metabolism.pdf
Bacterial Metabolism.pdf
SumanRiaz5
 
Respiration &pentose phosphate pathway
Respiration &pentose phosphate pathwayRespiration &pentose phosphate pathway
Respiration &pentose phosphate pathway
gohil sanjay bhagvanji
 
Biogas 1051.pptx
Biogas 1051.pptxBiogas 1051.pptx
Biogas 1051.pptx
zeeshan601564
 
Fermentative metabolism and development of bioprocessing technology, processi...
Fermentative metabolism and development of bioprocessing technology, processi...Fermentative metabolism and development of bioprocessing technology, processi...
Fermentative metabolism and development of bioprocessing technology, processi...
Ananya Sinha
 

Similar to FERMENTATION.pptx (20)

Fermentation and Microorganisms lesson 1.pptx
Fermentation and Microorganisms lesson 1.pptxFermentation and Microorganisms lesson 1.pptx
Fermentation and Microorganisms lesson 1.pptx
 
Food fermentation
Food fermentationFood fermentation
Food fermentation
 
Fermentation Presentation.pdf
Fermentation Presentation.pdfFermentation Presentation.pdf
Fermentation Presentation.pdf
 
Fermentation.pptx
Fermentation.pptxFermentation.pptx
Fermentation.pptx
 
Fermentation presentation
Fermentation presentationFermentation presentation
Fermentation presentation
 
Explain the difference between fermentation and respiration in biolo.pdf
Explain the difference between fermentation and respiration in biolo.pdfExplain the difference between fermentation and respiration in biolo.pdf
Explain the difference between fermentation and respiration in biolo.pdf
 
Fermentation of carbohydrates
Fermentation of carbohydratesFermentation of carbohydrates
Fermentation of carbohydrates
 
Fermentation and it's types
Fermentation and it's typesFermentation and it's types
Fermentation and it's types
 
Life sciences ebook
Life sciences  ebookLife sciences  ebook
Life sciences ebook
 
3.7 cell respiration
3.7 cell respiration3.7 cell respiration
3.7 cell respiration
 
3 130909221817-
3 130909221817-3 130909221817-
3 130909221817-
 
Respiration in Plants Class 11 Free Study Material pdf download
Respiration in Plants Class 11 Free Study Material pdf downloadRespiration in Plants Class 11 Free Study Material pdf download
Respiration in Plants Class 11 Free Study Material pdf download
 
Bacterial Metabolism.docx
Bacterial Metabolism.docxBacterial Metabolism.docx
Bacterial Metabolism.docx
 
PLANT RESPIRATION.pptx
PLANT RESPIRATION.pptxPLANT RESPIRATION.pptx
PLANT RESPIRATION.pptx
 
10 21 09 Lecture
10 21 09 Lecture10 21 09 Lecture
10 21 09 Lecture
 
Bacterial Metabolism.pdf
Bacterial Metabolism.pdfBacterial Metabolism.pdf
Bacterial Metabolism.pdf
 
Respiration &pentose phosphate pathway
Respiration &pentose phosphate pathwayRespiration &pentose phosphate pathway
Respiration &pentose phosphate pathway
 
Biogas 1051.pptx
Biogas 1051.pptxBiogas 1051.pptx
Biogas 1051.pptx
 
Fermentative metabolism and development of bioprocessing technology, processi...
Fermentative metabolism and development of bioprocessing technology, processi...Fermentative metabolism and development of bioprocessing technology, processi...
Fermentative metabolism and development of bioprocessing technology, processi...
 
Report
ReportReport
Report
 

More from BALASUNDARESAN M

ICH Quality Guidelines Summary QSEM .pdf
ICH Quality Guidelines Summary QSEM .pdfICH Quality Guidelines Summary QSEM .pdf
ICH Quality Guidelines Summary QSEM .pdf
BALASUNDARESAN M
 
Pharmaceutical Biotechnology VI semester.pdf
Pharmaceutical Biotechnology VI semester.pdfPharmaceutical Biotechnology VI semester.pdf
Pharmaceutical Biotechnology VI semester.pdf
BALASUNDARESAN M
 
Tablets Excipients in pharmaceutical formulations.pdf
Tablets Excipients in pharmaceutical formulations.pdfTablets Excipients in pharmaceutical formulations.pdf
Tablets Excipients in pharmaceutical formulations.pdf
BALASUNDARESAN M
 
PROCESS VALIDATION FOR CAPSULES (SOLID DOSAGE FORM).pdf
PROCESS VALIDATION FOR CAPSULES (SOLID DOSAGE FORM).pdfPROCESS VALIDATION FOR CAPSULES (SOLID DOSAGE FORM).pdf
PROCESS VALIDATION FOR CAPSULES (SOLID DOSAGE FORM).pdf
BALASUNDARESAN M
 
PHARMACEUTICAL EMULSION (BIPHASIC SYSTEM).pdf
PHARMACEUTICAL EMULSION (BIPHASIC SYSTEM).pdfPHARMACEUTICAL EMULSION (BIPHASIC SYSTEM).pdf
PHARMACEUTICAL EMULSION (BIPHASIC SYSTEM).pdf
BALASUNDARESAN M
 
CHROMATOGRAPHY - PHARMACEUTICAL ANALYSIS.pdf
CHROMATOGRAPHY - PHARMACEUTICAL ANALYSIS.pdfCHROMATOGRAPHY - PHARMACEUTICAL ANALYSIS.pdf
CHROMATOGRAPHY - PHARMACEUTICAL ANALYSIS.pdf
BALASUNDARESAN M
 
COMPUTER APPLICATIONS IN PHARMACY LAB MANUAL.pdf
COMPUTER APPLICATIONS IN PHARMACY LAB MANUAL.pdfCOMPUTER APPLICATIONS IN PHARMACY LAB MANUAL.pdf
COMPUTER APPLICATIONS IN PHARMACY LAB MANUAL.pdf
BALASUNDARESAN M
 
HVAC Validation (Air Handling Units).pdf
HVAC Validation (Air Handling Units).pdfHVAC Validation (Air Handling Units).pdf
HVAC Validation (Air Handling Units).pdf
BALASUNDARESAN M
 
Data Integrity Overview and data integrity test.pdf
Data Integrity Overview and data integrity test.pdfData Integrity Overview and data integrity test.pdf
Data Integrity Overview and data integrity test.pdf
BALASUNDARESAN M
 
Investigation of out of specifications.pdf
Investigation of out of specifications.pdfInvestigation of out of specifications.pdf
Investigation of out of specifications.pdf
BALASUNDARESAN M
 
What is 5S principles of trainers for training institutions.pdf
What is 5S principles of trainers for training institutions.pdfWhat is 5S principles of trainers for training institutions.pdf
What is 5S principles of trainers for training institutions.pdf
BALASUNDARESAN M
 
STABILITY STUDIES OF PHARMACEUTICALS.pdf
STABILITY STUDIES OF PHARMACEUTICALS.pdfSTABILITY STUDIES OF PHARMACEUTICALS.pdf
STABILITY STUDIES OF PHARMACEUTICALS.pdf
BALASUNDARESAN M
 
ANALYTICAL METHOD VALIDATION (PHARMACEUTICAL INDUSTRY).pdf
ANALYTICAL METHOD VALIDATION (PHARMACEUTICAL INDUSTRY).pdfANALYTICAL METHOD VALIDATION (PHARMACEUTICAL INDUSTRY).pdf
ANALYTICAL METHOD VALIDATION (PHARMACEUTICAL INDUSTRY).pdf
BALASUNDARESAN M
 
Pharmacology Short Notes for pharma students.pdf
Pharmacology Short Notes for pharma students.pdfPharmacology Short Notes for pharma students.pdf
Pharmacology Short Notes for pharma students.pdf
BALASUNDARESAN M
 
Pediatrics Doses schedule (pharmacology).pdf
Pediatrics Doses schedule (pharmacology).pdfPediatrics Doses schedule (pharmacology).pdf
Pediatrics Doses schedule (pharmacology).pdf
BALASUNDARESAN M
 
Tablet Manufacturing and Formulation Processing .pdf
Tablet Manufacturing and Formulation Processing .pdfTablet Manufacturing and Formulation Processing .pdf
Tablet Manufacturing and Formulation Processing .pdf
BALASUNDARESAN M
 
BASIC CONCEPTS OF HIGH PERFORMANCE LIQUID CHROMATOGRAPHY
BASIC CONCEPTS OF HIGH PERFORMANCE LIQUID CHROMATOGRAPHYBASIC CONCEPTS OF HIGH PERFORMANCE LIQUID CHROMATOGRAPHY
BASIC CONCEPTS OF HIGH PERFORMANCE LIQUID CHROMATOGRAPHY
BALASUNDARESAN M
 
High Performance Liquid Chromatography Qualification .pdf
High Performance Liquid Chromatography Qualification .pdfHigh Performance Liquid Chromatography Qualification .pdf
High Performance Liquid Chromatography Qualification .pdf
BALASUNDARESAN M
 
Introduction to Quality Management System .pdf
Introduction to Quality Management System .pdfIntroduction to Quality Management System .pdf
Introduction to Quality Management System .pdf
BALASUNDARESAN M
 
GOOD MANUFACTURING PRACTICES & SANITATION SOP
GOOD MANUFACTURING PRACTICES & SANITATION SOPGOOD MANUFACTURING PRACTICES & SANITATION SOP
GOOD MANUFACTURING PRACTICES & SANITATION SOP
BALASUNDARESAN M
 

More from BALASUNDARESAN M (20)

ICH Quality Guidelines Summary QSEM .pdf
ICH Quality Guidelines Summary QSEM .pdfICH Quality Guidelines Summary QSEM .pdf
ICH Quality Guidelines Summary QSEM .pdf
 
Pharmaceutical Biotechnology VI semester.pdf
Pharmaceutical Biotechnology VI semester.pdfPharmaceutical Biotechnology VI semester.pdf
Pharmaceutical Biotechnology VI semester.pdf
 
Tablets Excipients in pharmaceutical formulations.pdf
Tablets Excipients in pharmaceutical formulations.pdfTablets Excipients in pharmaceutical formulations.pdf
Tablets Excipients in pharmaceutical formulations.pdf
 
PROCESS VALIDATION FOR CAPSULES (SOLID DOSAGE FORM).pdf
PROCESS VALIDATION FOR CAPSULES (SOLID DOSAGE FORM).pdfPROCESS VALIDATION FOR CAPSULES (SOLID DOSAGE FORM).pdf
PROCESS VALIDATION FOR CAPSULES (SOLID DOSAGE FORM).pdf
 
PHARMACEUTICAL EMULSION (BIPHASIC SYSTEM).pdf
PHARMACEUTICAL EMULSION (BIPHASIC SYSTEM).pdfPHARMACEUTICAL EMULSION (BIPHASIC SYSTEM).pdf
PHARMACEUTICAL EMULSION (BIPHASIC SYSTEM).pdf
 
CHROMATOGRAPHY - PHARMACEUTICAL ANALYSIS.pdf
CHROMATOGRAPHY - PHARMACEUTICAL ANALYSIS.pdfCHROMATOGRAPHY - PHARMACEUTICAL ANALYSIS.pdf
CHROMATOGRAPHY - PHARMACEUTICAL ANALYSIS.pdf
 
COMPUTER APPLICATIONS IN PHARMACY LAB MANUAL.pdf
COMPUTER APPLICATIONS IN PHARMACY LAB MANUAL.pdfCOMPUTER APPLICATIONS IN PHARMACY LAB MANUAL.pdf
COMPUTER APPLICATIONS IN PHARMACY LAB MANUAL.pdf
 
HVAC Validation (Air Handling Units).pdf
HVAC Validation (Air Handling Units).pdfHVAC Validation (Air Handling Units).pdf
HVAC Validation (Air Handling Units).pdf
 
Data Integrity Overview and data integrity test.pdf
Data Integrity Overview and data integrity test.pdfData Integrity Overview and data integrity test.pdf
Data Integrity Overview and data integrity test.pdf
 
Investigation of out of specifications.pdf
Investigation of out of specifications.pdfInvestigation of out of specifications.pdf
Investigation of out of specifications.pdf
 
What is 5S principles of trainers for training institutions.pdf
What is 5S principles of trainers for training institutions.pdfWhat is 5S principles of trainers for training institutions.pdf
What is 5S principles of trainers for training institutions.pdf
 
STABILITY STUDIES OF PHARMACEUTICALS.pdf
STABILITY STUDIES OF PHARMACEUTICALS.pdfSTABILITY STUDIES OF PHARMACEUTICALS.pdf
STABILITY STUDIES OF PHARMACEUTICALS.pdf
 
ANALYTICAL METHOD VALIDATION (PHARMACEUTICAL INDUSTRY).pdf
ANALYTICAL METHOD VALIDATION (PHARMACEUTICAL INDUSTRY).pdfANALYTICAL METHOD VALIDATION (PHARMACEUTICAL INDUSTRY).pdf
ANALYTICAL METHOD VALIDATION (PHARMACEUTICAL INDUSTRY).pdf
 
Pharmacology Short Notes for pharma students.pdf
Pharmacology Short Notes for pharma students.pdfPharmacology Short Notes for pharma students.pdf
Pharmacology Short Notes for pharma students.pdf
 
Pediatrics Doses schedule (pharmacology).pdf
Pediatrics Doses schedule (pharmacology).pdfPediatrics Doses schedule (pharmacology).pdf
Pediatrics Doses schedule (pharmacology).pdf
 
Tablet Manufacturing and Formulation Processing .pdf
Tablet Manufacturing and Formulation Processing .pdfTablet Manufacturing and Formulation Processing .pdf
Tablet Manufacturing and Formulation Processing .pdf
 
BASIC CONCEPTS OF HIGH PERFORMANCE LIQUID CHROMATOGRAPHY
BASIC CONCEPTS OF HIGH PERFORMANCE LIQUID CHROMATOGRAPHYBASIC CONCEPTS OF HIGH PERFORMANCE LIQUID CHROMATOGRAPHY
BASIC CONCEPTS OF HIGH PERFORMANCE LIQUID CHROMATOGRAPHY
 
High Performance Liquid Chromatography Qualification .pdf
High Performance Liquid Chromatography Qualification .pdfHigh Performance Liquid Chromatography Qualification .pdf
High Performance Liquid Chromatography Qualification .pdf
 
Introduction to Quality Management System .pdf
Introduction to Quality Management System .pdfIntroduction to Quality Management System .pdf
Introduction to Quality Management System .pdf
 
GOOD MANUFACTURING PRACTICES & SANITATION SOP
GOOD MANUFACTURING PRACTICES & SANITATION SOPGOOD MANUFACTURING PRACTICES & SANITATION SOP
GOOD MANUFACTURING PRACTICES & SANITATION SOP
 

Recently uploaded

Multi-source connectivity as the driver of solar wind variability in the heli...
Multi-source connectivity as the driver of solar wind variability in the heli...Multi-source connectivity as the driver of solar wind variability in the heli...
Multi-source connectivity as the driver of solar wind variability in the heli...
Sérgio Sacani
 
Richard's entangled aventures in wonderland
Richard's entangled aventures in wonderlandRichard's entangled aventures in wonderland
Richard's entangled aventures in wonderland
Richard Gill
 
EY - Supply Chain Services 2018_template.pptx
EY - Supply Chain Services 2018_template.pptxEY - Supply Chain Services 2018_template.pptx
EY - Supply Chain Services 2018_template.pptx
AlguinaldoKong
 
platelets- lifespan -Clot retraction-disorders.pptx
platelets- lifespan -Clot retraction-disorders.pptxplatelets- lifespan -Clot retraction-disorders.pptx
platelets- lifespan -Clot retraction-disorders.pptx
muralinath2
 
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Sérgio Sacani
 
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...
Scintica Instrumentation
 
Cancer cell metabolism: special Reference to Lactate Pathway
Cancer cell metabolism: special Reference to Lactate PathwayCancer cell metabolism: special Reference to Lactate Pathway
Cancer cell metabolism: special Reference to Lactate Pathway
AADYARAJPANDEY1
 
extra-chromosomal-inheritance[1].pptx.pdfpdf
extra-chromosomal-inheritance[1].pptx.pdfpdfextra-chromosomal-inheritance[1].pptx.pdfpdf
extra-chromosomal-inheritance[1].pptx.pdfpdf
DiyaBiswas10
 
ESR_factors_affect-clinic significance-Pathysiology.pptx
ESR_factors_affect-clinic significance-Pathysiology.pptxESR_factors_affect-clinic significance-Pathysiology.pptx
ESR_factors_affect-clinic significance-Pathysiology.pptx
muralinath2
 
Viksit bharat till 2047 India@2047.pptx
Viksit bharat till 2047  India@2047.pptxViksit bharat till 2047  India@2047.pptx
Viksit bharat till 2047 India@2047.pptx
rakeshsharma20142015
 
GBSN- Microbiology (Lab 3) Gram Staining
GBSN- Microbiology (Lab 3) Gram StainingGBSN- Microbiology (Lab 3) Gram Staining
GBSN- Microbiology (Lab 3) Gram Staining
Areesha Ahmad
 
Seminar of U.V. Spectroscopy by SAMIR PANDA
 Seminar of U.V. Spectroscopy by SAMIR PANDA Seminar of U.V. Spectroscopy by SAMIR PANDA
Seminar of U.V. Spectroscopy by SAMIR PANDA
SAMIR PANDA
 
Hemostasis_importance& clinical significance.pptx
Hemostasis_importance& clinical significance.pptxHemostasis_importance& clinical significance.pptx
Hemostasis_importance& clinical significance.pptx
muralinath2
 
justice-and-fairness-ethics with example
justice-and-fairness-ethics with examplejustice-and-fairness-ethics with example
justice-and-fairness-ethics with example
azzyixes
 
Citrus Greening Disease and its Management
Citrus Greening Disease and its ManagementCitrus Greening Disease and its Management
Citrus Greening Disease and its Management
subedisuryaofficial
 
In silico drugs analogue design: novobiocin analogues.pptx
In silico drugs analogue design: novobiocin analogues.pptxIn silico drugs analogue design: novobiocin analogues.pptx
In silico drugs analogue design: novobiocin analogues.pptx
AlaminAfendy1
 
Nutraceutical market, scope and growth: Herbal drug technology
Nutraceutical market, scope and growth: Herbal drug technologyNutraceutical market, scope and growth: Herbal drug technology
Nutraceutical market, scope and growth: Herbal drug technology
Lokesh Patil
 
erythropoiesis-I_mechanism& clinical significance.pptx
erythropoiesis-I_mechanism& clinical significance.pptxerythropoiesis-I_mechanism& clinical significance.pptx
erythropoiesis-I_mechanism& clinical significance.pptx
muralinath2
 
The ASGCT Annual Meeting was packed with exciting progress in the field advan...
The ASGCT Annual Meeting was packed with exciting progress in the field advan...The ASGCT Annual Meeting was packed with exciting progress in the field advan...
The ASGCT Annual Meeting was packed with exciting progress in the field advan...
Health Advances
 
Structural Classification Of Protein (SCOP)
Structural Classification Of Protein  (SCOP)Structural Classification Of Protein  (SCOP)
Structural Classification Of Protein (SCOP)
aishnasrivastava
 

Recently uploaded (20)

Multi-source connectivity as the driver of solar wind variability in the heli...
Multi-source connectivity as the driver of solar wind variability in the heli...Multi-source connectivity as the driver of solar wind variability in the heli...
Multi-source connectivity as the driver of solar wind variability in the heli...
 
Richard's entangled aventures in wonderland
Richard's entangled aventures in wonderlandRichard's entangled aventures in wonderland
Richard's entangled aventures in wonderland
 
EY - Supply Chain Services 2018_template.pptx
EY - Supply Chain Services 2018_template.pptxEY - Supply Chain Services 2018_template.pptx
EY - Supply Chain Services 2018_template.pptx
 
platelets- lifespan -Clot retraction-disorders.pptx
platelets- lifespan -Clot retraction-disorders.pptxplatelets- lifespan -Clot retraction-disorders.pptx
platelets- lifespan -Clot retraction-disorders.pptx
 
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
 
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...
 
Cancer cell metabolism: special Reference to Lactate Pathway
Cancer cell metabolism: special Reference to Lactate PathwayCancer cell metabolism: special Reference to Lactate Pathway
Cancer cell metabolism: special Reference to Lactate Pathway
 
extra-chromosomal-inheritance[1].pptx.pdfpdf
extra-chromosomal-inheritance[1].pptx.pdfpdfextra-chromosomal-inheritance[1].pptx.pdfpdf
extra-chromosomal-inheritance[1].pptx.pdfpdf
 
ESR_factors_affect-clinic significance-Pathysiology.pptx
ESR_factors_affect-clinic significance-Pathysiology.pptxESR_factors_affect-clinic significance-Pathysiology.pptx
ESR_factors_affect-clinic significance-Pathysiology.pptx
 
Viksit bharat till 2047 India@2047.pptx
Viksit bharat till 2047  India@2047.pptxViksit bharat till 2047  India@2047.pptx
Viksit bharat till 2047 India@2047.pptx
 
GBSN- Microbiology (Lab 3) Gram Staining
GBSN- Microbiology (Lab 3) Gram StainingGBSN- Microbiology (Lab 3) Gram Staining
GBSN- Microbiology (Lab 3) Gram Staining
 
Seminar of U.V. Spectroscopy by SAMIR PANDA
 Seminar of U.V. Spectroscopy by SAMIR PANDA Seminar of U.V. Spectroscopy by SAMIR PANDA
Seminar of U.V. Spectroscopy by SAMIR PANDA
 
Hemostasis_importance& clinical significance.pptx
Hemostasis_importance& clinical significance.pptxHemostasis_importance& clinical significance.pptx
Hemostasis_importance& clinical significance.pptx
 
justice-and-fairness-ethics with example
justice-and-fairness-ethics with examplejustice-and-fairness-ethics with example
justice-and-fairness-ethics with example
 
Citrus Greening Disease and its Management
Citrus Greening Disease and its ManagementCitrus Greening Disease and its Management
Citrus Greening Disease and its Management
 
In silico drugs analogue design: novobiocin analogues.pptx
In silico drugs analogue design: novobiocin analogues.pptxIn silico drugs analogue design: novobiocin analogues.pptx
In silico drugs analogue design: novobiocin analogues.pptx
 
Nutraceutical market, scope and growth: Herbal drug technology
Nutraceutical market, scope and growth: Herbal drug technologyNutraceutical market, scope and growth: Herbal drug technology
Nutraceutical market, scope and growth: Herbal drug technology
 
erythropoiesis-I_mechanism& clinical significance.pptx
erythropoiesis-I_mechanism& clinical significance.pptxerythropoiesis-I_mechanism& clinical significance.pptx
erythropoiesis-I_mechanism& clinical significance.pptx
 
The ASGCT Annual Meeting was packed with exciting progress in the field advan...
The ASGCT Annual Meeting was packed with exciting progress in the field advan...The ASGCT Annual Meeting was packed with exciting progress in the field advan...
The ASGCT Annual Meeting was packed with exciting progress in the field advan...
 
Structural Classification Of Protein (SCOP)
Structural Classification Of Protein  (SCOP)Structural Classification Of Protein  (SCOP)
Structural Classification Of Protein (SCOP)
 

FERMENTATION.pptx

  • 1. MODULE- 5 FERMENTA TIONAND BLOOD PRODUCTS BALASUNDARESAN M B Pharmacy 6th sem Subject: Pharmaceutical Biotechnology SubjectCode: BP605T
  • 2. Objectives of Course •Appreciate the use of microorganisms technology. • Genetic engineering applications in relation in fermentation to production of pharmaceuticals. Learning Outcomes • Students will learn about various fermentation methods including their sterlization methods, aeration and stirring methods. •They will also learn about various types of fermentor design and parameters used to control fermentation process.
  • 3. Definition: Fermentation is the chemical transformation of organic substances into simpler compounds by the action of enzymes, complex organic catalysts, which are produced by microorganisms such as molds, yeasts, or bacteria. Enzymes act by hydrolysis, a process of breaking down or predigesting complex organic molecules to form smaller (and in the case of foods, more easily digestible) compounds and nutrients.
  • 4.
  • 5. HISTORY OF FERMENTATION Fermentation is a natural process. People applied fermentation to make products such as wine, mead (Made of Fermented honey and water), cheese and beer long before the biochemical process was understood. In the 1850s and 1860s Louis Pasteur became the first zymurgist (One who
  • 6. expert in the field of fermentation) or scientist to study fermentation when he demonstrated fermentation was caused by living cells. The first solid evidence of the living nature of yeast appeared between 1837 and 1838 when three publications appeared by C. Cagniard de la Tour, T. Swann, and F. Kuetzing, each of whom independently concluded as a result of microscopic investigations that yeast was a living organism that reproduced by budding. The word "yeast," it
  • 7. should be noted, traces its origins back to the Sanskrit word meaning "boiling." It was perhaps because wine, beer, and bread were each basic foods in Europe, that most of the early studies on fermentation were done on yeasts, with which they were made. Soon bacteria were also discovered; the term was first used in English in the late 1840s, but it did not come into general use until the 1870s, and then largely in connection with the new germ theory of disease. The view that fermentation was a process initiated by living organisms soon aroused fierce criticism from the finest
  • 8. chemists of the day, especially Justus von Liebig, J.J. Berzelius, and Friedrich Woehler. This view seemed to give new life to the waning mystical philosophy of vitalism, which they had worked so hard to defeat. Proponents of vitalism held that the functions of living organisms were due to a vital principal (life force, chi, ki, prana , etc.) distinct from physico- chemical forces, that the processes of life were not explicable by the laws of physics and chemistry alone, and that life was in some part self determining. As we shall soon see, the vitalists played a key role in debate on the nature of
  • 9. fermentation. A long battle ensued, and while it was gradually recognized that yeast was a living organism, its exact function in fermentations remained a matter of controversy. The chemists still maintained that fermentation was due to catalytic action or molecular vibrations. The debate was finally brought to an end by the great French chemist Louis Pasteur (1822-1895) who, during the 1850s and 1860s, in a series of classic investigations, proved conclusively that fermentation was initiated by living organisms. In 1857 Pasteur showed that lactic acid
  • 10. fermentation is caused by living organisms. In 1860 he demonstrated that bacteria cause souring in milk, a process formerly thought to be merely a chemical change, and his work in identifying the role of microorganisms in food spoilage led to the process of pasteurization. In 1877, working to improve the French brewing industry, Pasteur published his famous paper on fermentation, Etudes sur la Biere , which was translated into English in 1879 as Studies on Fermentation . He defined fermentation (incorrectly) as "Life without air," but correctly showed specific types of
  • 11. microorganisms cause specific types of fermentations and specific end products. In 1877 the era of modern medical bacteriology began when Koch (a German physician; 1843- 1910) and Pasteur showed that the anthrax bacillus caused the infectious disease anthrax. This epic discovery led in 1880 to Pasteur's general germ theory of infectious disease, which postulated for the first time that each such disease was caused by a specific microorganism. Koch also made the very significant discovery of a method for isolating microorganisms in pure culture.
  • 12. TYPES BASED ON RESPIRATION (AEROBIC AND AN-AEROBIC) Aerobic Fermentation: Aerobic fermentation means that oxygen is present. Wine, beer and acetic acid vinegar (such as apple cider vinegar), need oxygen in the “primary” or first stage of fermentation. When creating acetic vinegar, for example, exposing the surface of the vinegar to as much oxygen as possible, creates a healthy, flavorful vinegar with the correct pH.
  • 13. Anaerobic Fermentation: Anaerobic fermentation is a method cells use to extract energy from carbohydrates when oxygen or other electron acceptors are not available in the surrounding environment. This differentiates it from anaerobic respiration, which doesn’t use oxygen but does use electron-accepting molecules that come from outside of the cell. The process can follow glycolysis as the next step in the breakdown of glucose and other sugars to produce molecules of adenosine triphosphate (ATP) that create an energy source for the cell.
  • 14. Through this method, a cell is able to regenerate nicotinamide adenine dinucleotide (NAD+) from the reduced form of nicotinamide adenine dinucleotide (NADH), a molecule necessary to continue glycolysis. Anaerobic fermentation relies on enzymes to add a phosphate group to an individual adenosine diphosphate (ADP) molecule to produce A TP , which means it is a form of substrate-level phosphorylation. This contrasts with oxidative phosphorylation, which uses energy from an established proton gradient to produceA TP .
  • 15. There are two major types of anaerobic fermentation: ethanol fermentation and lactic acid fermentation. Both restore NAD+ to allow a cell to continue generating ATP through glycolysis. Ethanol fermentation: Ethanol fermentation converts two pyruvate molecules, the products of glycolysis, to two molecules of ethanol and two molecules of carbon dioxide. The reaction is a two-step process in which pyruvate is converted to acetaldehyde and carbon dioxide first, by the enzyme pyruvate decarboxylase.
  • 16. Yeast and certain bacteria perform ethanol where pyruvate (from glucose fermentation metabolism) is broken into ethanol and carbon dioxide. The net chemical for the production of ethanol from equation glucose is: C6H12O6 (glucose) → 2 C2H5OH (ethanol) + 2 CO2 (carbon dioxide) Ethanol fermentation is used the production of beer, wine and bread. It's worth noting that fermentation in the presence of high levels of pectin result in the production of small amounts of methanol, which is toxic when consumed.
  • 18. Lactic acid fermentation: Lactic acid fermentation is a biological process by which glucose and other six-carbon sugars (also, disaccharides of six-carbon sugars, e.g. sucrose or lactose) are converted into cellular energy and the metabolite lactate. The pyruvate molecules from glucose metabolism (glycolysis) may be fermented into lactic acid. Lactic acid fermentation is used to convert lactose into lactic acid in yogurt production. It also occurs in animal muscles when
  • 19. the tissue requires energy at a faster rate than oxygen can be supplied. The next equation for lactic acid production from glucose is: C6H12O6 (glucose) → 2 CH3CHOHCOOH (lacticacid) The production of lactic acid from lactose and water may be summarized as: C12H22O11 (lactose) + H2O (water) → 4 CH3CHOHCOOH (lactic acid) Yogurt is made by fermenting milk. It's high in protein, calcium, and probiotics ("good" bacteria). Here's how to make yogurt and a look at the chemistry of yogurt.
  • 20. TYPES OFFERMENTATION Homo Lactic fermentation: The fermentation in which only the lactic acid is produced. There is no any side product formed after the reaction. Hetero-Lactic Fermentation: The Fermentation in which the lactic acid is produced along with some by products like gases.
  • 21. MECHANISM OF FERMENTATION Fermentation takes place when the electron transport chain is unusable (often due to lack of a final electron receptor, such as oxygen), and becomes the cell’s primary means of ATP (energy) production.[1] It turns NADH and pyruvate produced in glycolysis into NAD+ and an organic molecule (which varies depending on the type of fermentation; see examples below). In the presence of O2, NADH and pyruvate are used to generateA TPin respiration. This iscalled
  • 22. oxidative phosphorylation, and it generates much more ATP than glycolysis alone. For that reason, cells generally benefit from avoiding fermentation when oxygen is available, the exception being obligate anaerobes which cannot tolerate oxygen. The first step, glycolysis, is common to all fermentation pathways this is the cause of fermentation: C6H12O6 + 2 NAD+ + 2 ADP + 2 Pi → 2 CH3COCOO− + 2 NADH + 2A TP+ 2 H2O + 2H+ Pyruvate is CH3COCOO−. Pi is inorganic phosphate. Two ADP molecules and two Pi are converted to two ATP and two water molecules via substrate-level phosphorylation. Two molecules of NAD+ are also reduced to NADH.
  • 23. In oxidative phosphorylation the energy for A TP formation is derived from an electrochemical proton gradient generated across the inner mitochondrial membrane (or, in the case of bacteria, the plasma membrane) via the electron transport chain. Glycolysis has substrate-level phosphorylation (ATP generated directly at the point of reaction). Humans have used fermentation to produce food and beverages since the Neolithic age. For example,
  • 24. fermentation is used for preservation in a process that produces lactic acid as found in such sour foods as pickled cucumbers, kimchi and yogurt (see fermentation in food processing), as well as for producing alcoholic beverages such as wine (see fermentation in winemaking) and beer. Fermentation can even occur within the stomachs of animals, such as humans.
  • 25. PRODUCTS OF FERMENTATION Wine Beer Lactic acid Vinegar Y ogurts  cheese  Sauerkraut  Kimchi  Pepperoni ETC………..
  • 26.
  • 32. FERMENTATION AS A FOOD PRESERVATION TECHNIQUE Fermented foods are foods that have been prepared in a way so that the bacteria naturally found within them starts to ferment. Fermentation, also known as lacto-fermentation, is a chemical process in which bacteria and other micro-organisms break down starches and sugars within the foods, possibly making them easier to digest, and resulting in a product that is filled with helpful organisms and enzymes. This process of fermentation is a natural preservative, which means that fermented foods can last a long time.
  • 33. ADVANTAGES AND DIS ADVANTAGES OF FERMENTATION Advantages of fermentation are that lactic acid can be produced and it can produce energy forATPs. Disadvantages of fermentation are that production can be slow, the product is impure and needs to have further treatment and the production carries a high cost and more energy.
  • 34. IMPORTANCE OF FERMENTATION Fermentation is important to cells that don't have oxygen or cells that don't use oxygen because: 1.It allows the cells to get 2 ATPgain from onemolecule of glucose, even without oxygen. 2.Fermentation takes away the end products of glycolysis so glycolysis can continue ... freeing up the electron carriers, and so on.
  • 35. 3.Fermentation is important to the baking industry because it is the process that yeast uses to produce the bubbles of carbon dioxide that make the dough rise. 4.Fermentation is important in wineries and breweries because yeast uses fermentation to produce alcohol. 5.Fermentation is important in muscles because it allows the muscles to keep getting a little energy from glucose even when the oxygen supply can't keep up with the demand.
  • 37. Introduction Blood: It consistsof 1. Cells i.e. RBC, WBC, Platelets 2. Plasma i.e. Proteins, Coagulation factors Blood Substitutes: It consistsof 1. Volume Expanders 2. Synthetic oxygen carriers Blood Products: : Any therapeutic substance prepared from the blood. It consists of Blood Components Constituent separated from whole blood Plasma Derivatives 1. Red cell concentrate 2. Leuko-reduced RBC 3. Plasma 4. Plasma derivatives 5. Granulocyte concentrate 6. Platelet concentrate 1. Fresh frozen plasma 2. Cryoprecipitate 3. Albumin 4. Coagulation factors concentrate 5. Immunoglobulins
  • 38. Collection  350ml{301ml blood+49ml anticoagulant} is taken from previously screened person .  Tested for- syphilis, HBsAg, HCV, HIV 1&2  Platelet concentrates for bacterial contamination  Group determination (ABO & Rh) & presence of any RBC antibody  Processed into sub-components
  • 39. Criteria for donor ▶ Normal body temperature, Blood pressure ▶ Weight above 50-55 kgs ▶ Normal Hb levels.. ▶ Free from RTI, skin dz or blood dz ▶ No h/o drug addiction ▶ No h/o viral hepatitis ▶ No HIV infection or risk for it ▶ No h/o blood transfusion (<=6mo)
  • 40. Whole Blood ▶ It is donor blood mixed with an anticoagulant ▶ Collected by venesection ▶ Collected in 63 ml of anticoagulant to form 450 ml. “ “ “ 350 ml OR, in 49 ml “ “ “ ▶ Stored at 1-6º C ▶ Shelf Life up to 5 weeks ▶ 1 unit{350ml} will increase the Hb level of an Adult (60-70Kg) Pediatric pts by 0.8 gm/dl by 1gm/dl
  • 41. • Indication : • Exchange transfusions. • Hemorrhage (>= 20%blood loss): -To ↑O₂ carrying capacity -volume replacement -stabilize coagulation factors Advantages : • simple and inexpensive • no special equipment required for processing Disadvantages : •Risk of circulatory overload •Maintaining at ~4oC leads to: -platelet dysfunction -degradation of coagulation factors -decreased 2,3 DPG levels • Febrile reactions • Narrow Shelf life- 5wks
  • 42. Preservation techniques ▶ Chemical incorporation ▶ Rejuvenation solutions ▶ Additive solutions ▶ Red cell freezing ▶ Addition of buffers
  • 43. Anticoagulants Citrate -chief component of almost all anticoagulants used chelates Ca2+ ... stops coagulation Dextrose- energy source. Phosphate- buffer 1. CG (sod.citrate+glucose)- 1st soln ever used 2. ACD (acid+citrate+dextrose) 3. CPD (citrate+phosphate+dextrose)- Higher pH & 2,3 DPG level is maintained. SHELF-LIFE is 21 days.
  • 44. 4.CPDA (+adenine)- ATP production ADP levels- glycolysis- increases RBC viability to 35 days 5.SAG-M (saline+adenine+glucose+mannitol)- maintains cell nutrition increases viability to 42 days, M-prevents spontaneous hemolysis
  • 45. Red cel concentrate Blood to separate under gravity (sedimentation method) Or,Centrifugation done in special refrigerated centrifuge Most of the plasma is removed and replaced with a solution of glucose and adenine in saline to maintain viability of red cells.  Maintained at temp : 2ºC to 6ºC  High O₂ carrying capacity  Optimal target for infusion- 7g/dl  Indications: - replacement of red cells in anemic patients - acute massive blood loss
  • 46. Advantages :  Easy to prepare  To avoid volume overload in c/o CCF  Less chances of infection or alloimmunization  Less immunosuppressant  Dec. allergic reaction if plasma is also removed Disadvantages :  High Red cells to plasma ratio ↑viscosity .·. ↑ time required for passing through cannula & vessels thus Hct should not exceed 80%
  • 47. Platelet concentrates  Platelets separated from plasma obtained after 4-6 donations are pooled or, from a single donor by plateletapheresis  Composed of mainly platelets, some nonfunctional WBCs, few RBCs & plasma[maintains pH]. volume= 50 ml contains 5.5x10^9/lt plts Stored at 20-24oC Shelf life- 5 days.. Once opened, transfuse within 6 hrs 1 unit of PC increases platelet count by: 5000-10000(adults) 20,000 (children) 75,000-1,00,000(infants)
  • 48. If single donor- 1 unit of PC should contain >5.5 х 10 9platelets If pooled then, > 250х 109 platelets • Indications: - Thrombocytopenia - Platelet dysfunction - Complication of anti-platelet therapy(Clopidogrel) - DIC
  • 49. Fresh Frozen Plasma  Stored at -40 to -50oC  Composed of plasma, all coagulation factors, albumin & Ig  1 unit= 200-250ml  Plasma removed from a unit of whole blood & frozen (by immersing in a solid carbondioxide and ethyl alcohol  mixture) at/ below -25ºC within 4 hrs. ofcollection.  Each unit of FFP increases the level of each clotting factor by 2-3 %  Shelf life: Frozen—1 year(<-30 degree centigrade)
  • 50. Indications: -active bleeding in pts with multiple factor deficiencies -surgery in patient with liver failure(treatment of choice) -after massive transfusion -DIC -rapid reversal of warfarin(Prothrombim complex concentrates,with factors II,IX,X can also be given) -TTP Advantage: it is a acellular component so no chance of transmission of intracellular infection
  • 51. Cryoprecipitate ▶ When FFP is allowed to Thaw at 4oC, glutinous precipitate remains and, if the suprenatant plasma is removed, cryoprecipitate ▶ contains factors VIII (very rich) , fibrinogen as well as factor XIII & vwf. at -40oC ▶Shelf life:2 years , if frozen Used 1. If fibrinogen <1g/dl due to dilution 2. DIC 3. Von Willebrand disease and hemophilia VIII deficiency
  • 52. Coagulation Factors Factor VIII concentrate  Prepared from large pools of donor plasma by fractionation process.  Commercially prepared, lyophilized powder  Hemophilia A & von Willebrand’s disease.  Storage : 2 to 6°C Factor IX  Commercially prepared, lyophilized powder  Hemophilia B  Contains Factor II (prothrombin), VII,IX,X.  Purified Factor IX contains only IX.  Refrigerated at 35-45 °F
  • 53. Immunoglobulin ▶ It is a concentrated solution of IgG antibody component of plasma ▶ Prepared from large pools of donors ▶ Uses 1. To reduce infective complications in patients with Ab deficiencies 2. Immunological d/o- Immune thrombocytopenia, GBS 3. Anti-zoster Ig in varicella zoster prophylaxis 4. Anti-Rhesus D Ig in pregnancy to prevent hemolytic dsz in newborn ▶ Can Cause ▶ Acute renal failure ( in elderly) ▶ Acute reactions Fibrinogen ▶ Prepared by organic liquid fractionation of plasma ▶ Stored in dried form ▶ Can be reconstituted with distilled water ▶ Used in cases of severe fibrinogendepletion eg DIC, congenital afibrinogenaemia ▶ Carry high risk of hepatitis
  • 54. Blood Substitutes 1. volume expanders 2. synthetic oxygen carriers 1.Volume expanders: inert compounds • crystalloid-based • colloid-based Ringer's lactate Normal saline D5W (dextrose 5% in water) Dextrose with normal saline Hypertonic saline • Dextrans • Albumin • Gelofusin • Hydroxyethyl starch
  • 55. Crystalloids a) Is isotonic, but with the metabolism of glucose  inside the body, becomes hypotonic. b) Blood cannot be given through the same drip set otherwise rouleaux formation will cause clumping of RBCs 4) Dextrose Normal Saline (DNS) a) Is hypertonic b) But 1/5 NS +4.3% dextose and ¼ NS +5% dextrose are isotonic and are best used as maintenance fluids. 1) ) Ringer’s Lactate Solution(Hartman Solution) a) Consists of Na, Cl, K, Ca, Lactate. pH=6.5, Osmolarity=273mmol/lt (slightly hypotonic) b) Blood should not be given through the same drip set as it contains Ca. c) Crystalloid of choice for blood loss replacement. 2) ) Normal Saline {0.9% NaCl (isotonic)} a) Preferred over RL for treating • Hypochloremic metabolic alkalosis • Brain injury (Ca2+ and lactate can increase the neuronal injury) • Hyponatremia ▶ 3)5% Dextose
  • 56. Colloids ▶ ▶ 1) Dextrans (Lomodex) ▶ Polysaccharides, can be stored for 10 years, half life=2-8 hours ▶ Advantages a) Non toxic, neutral and chemically inert b) Low molecular wt dextran improves microcirculation ▶ Drawbacks a) Interfere with blood grouping and cross matching (by causing RBC aggregation, so a blood sample should be taken before-hand) b) Interferes with platelet function and is a/w abnormal bleeding (so total volume given should not exceed 1000ml) c) Can cause severe anaphylaxis d) Large molecular weight dextrans can block renal tubules e) ARDS (rarely) because of direct toxic effect on pulmonary capillaries
  • 57. ▶ 2)Albumin(available as 5% and 20% solution) ▶ Very expensive, intravascular half-life= 10-15days ▶ Used in protein loss like, peritonitis, liver failure, burns, protein losing enterepathies. ▶ 20% is hypertonic and expands plasma volume by more than the amount infused. ▶ Stored for several months in liquid form at 4degree ▶ 3)Gelatins (Haemaccel)(available as 3.5% solution) ▶ Consists of Gelatin, Na, Cl, K, Ca ▶ Expand plasma effectively for 2 hours ▶ At clinically used doses, these do not interfere with blood grouping, plt fxn and clotting but at high doses can interfere clotting. ▶ As it contains high Calcium, citrated blood should not be mixed.
  • 58. Synthetic oxygen carriers: mimic blood's O₂ transport ability Types 1. Abiotic - perfluorocarbons, perfluoroctyl bromide 2. Biomimetic - HBOC( Hb based oxygen carriers) - recombinant erythropoietin, hemoglobin under clinical trials some available products: Hemopure Oxygent PolyHeme
  • 59. Perfluorocarbons ▶ High O₂ carryingcapacity ▶ Emulsified and transfused ▶ Short survival in the circulation ▶ Adverse effects : Flu like symptoms. Immunologic effects. HBOC ▶ Hb synthesised by controlled lysis of Red Cells ▶ Short half life as compared to RBCs ▶ Side effects : GI distress, neurotoxicity, vasoconstriction, interfere with macrophage system.